These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33155069)

  • 1. Risk factor of mediastinal lymph node metastasis of Siewert type I and II esophagogastric junction carcinomas.
    Nishiwaki N; Noma K; Matsuda T; Maeda N; Tanabe S; Sakurama K; Shirakawa Y; Fujiwara T
    Langenbecks Arch Surg; 2020 Dec; 405(8):1101-1109. PubMed ID: 33155069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
    Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
    Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study.
    Matsuda T; Kurokawa Y; Yoshikawa T; Kishi K; Misawa K; Ohi M; Mine S; Hiki N; Takeuchi H
    World J Surg; 2016 Jul; 40(7):1672-9. PubMed ID: 26928855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study.
    Qi X; Liu M; Xu K; Tan F; Gao P; Yao Z; Zhang N; Yang H; Zhang C; Xing J; Cui M; Su X
    Surg Endosc; 2024 Jul; 38(7):3828-3837. PubMed ID: 38822144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
    Luo SJ; Xiong WW; Chen Y; Li ZY; Li E; Zeng HP; Zheng YS; Luo LJ; Li J; Cui ZM; Wan J; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Aug; 24(8):684-690. PubMed ID: 34412185
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the surgical treatment strategies for Siewert type II squamous cell carcinoma in the same area as esophagogastric junction carcinoma: data from a single Japanese high-volume cancer center.
    Yabusaki H; Nashimoto A; Matsuki A; Aizawa M
    Surg Today; 2014 Aug; 44(8):1522-8. PubMed ID: 24166133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of lymph node dissection in Siewert II adenocarcinoma of the esophagogastric junction.
    Tian Y; Lv H; Wang M; Tian Z
    J Cardiothorac Surg; 2024 Jul; 19(1):460. PubMed ID: 39026299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors.
    Sakaki A; Kanamori J; Ishiyama K; Kurita D; Oguma J; Daiko H
    Langenbecks Arch Surg; 2020 Jun; 405(4):509-519. PubMed ID: 32514766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.
    Kurokawa Y; Takeuchi H; Doki Y; Mine S; Terashima M; Yasuda T; Yoshida K; Daiko H; Sakuramoto S; Yoshikawa T; Kunisaki C; Seto Y; Tamura S; Shimokawa T; Sano T; Kitagawa Y
    Ann Surg; 2021 Jul; 274(1):120-127. PubMed ID: 31404008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer.
    Shiraishi O; Yasuda T; Kato H; Iwama M; Hiraki Y; Yasuda A; Shinkai M; Kimura Y; Imano M
    Ann Surg Oncol; 2020 Oct; 27(11):4433-4440. PubMed ID: 32409967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.
    Kakeji Y; Yamamoto M; Ito S; Sugiyama M; Egashira A; Saeki H; Morita M; Sakaguchi Y; Toh Y; Maehara Y
    Surg Today; 2012 Apr; 42(4):351-8. PubMed ID: 22245924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal surgical management for esophagogastric junction carcinoma.
    Matsuda T; Takeuchi H; Tsuwano S; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Gen Thorac Cardiovasc Surg; 2014 Sep; 62(9):560-6. PubMed ID: 24570201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.
    Wu XN; Liu CQ; Tian JY; Guo MF; Xu MQ
    Int J Surg; 2017 May; 41():6-11. PubMed ID: 28323156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
    Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
    Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of outcomes after surgery between adenocarcinoma of the esophagogastric junction and lower thoracic esophageal squamous cell cancer].
    Fu SJ; Fang WT; Mao T; Feng J; Gu ZT; Chen WH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):893-6. PubMed ID: 22990917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.